These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14258516)

  • 1. [ON THE ACTIVATION OF PROTEOLYTIC PROENZYMES OF THE PANCREAS].
    NAGEL W; ROBEL KP; WILLIG F
    Klin Wochenschr; 1965 Feb; 43():173-4. PubMed ID: 14258516
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE INHIBITION OF THE ACTIVIZATION OF PROTEOLYTIC ENZYMES IN RAT PANCREATIC HOMOGENATES AND OF ALPHA-CHYMOTRYPSINOGEN BY EPSILON-AMINOCAPROIC ACID AND P-AMINO-METHYL-BENZOIC ACID].
    TRETTIN HJ
    Z Gesamte Inn Med; 1964 Sep; 19():729-30. PubMed ID: 14232734
    [No Abstract]   [Full Text] [Related]  

  • 3. [INTRAPANCREATIC ACTIVATION OF PROTEOLYTIC ENZYMES AND THE EFFECT OF TRASYLOL IN EXPERIMENTAL PANCREATITIS IN RATS].
    CREUTZFELDT W; SOELING HD; KETTERER H
    Klin Wochenschr; 1963 Oct; 41():1002-7. PubMed ID: 14094378
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF A TRYPSIN-INHIBITOR (TRASYLOL) IN EXPERIMENTAL PANCREATITIS.
    BERGENTZ SE; EDLUND Y
    Acta Chir Scand; 1964 Jun; 127():657-61. PubMed ID: 14175140
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of protease tissue inhibitor on the activity of pancreatic proteolytic enzymes in in-vitro experiments].
    Egorova EF; Chernoiarova OD; Ryzhkova GI
    Eksp Klin Farmakol; 1992; 55(3):39-41. PubMed ID: 1458161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PROTEOLYTIC ENZYMES IN THE PANCREAS IN NORMAL AND PATHOLOGICAL CONDITIONS].
    NAGEL W; WILLIG F
    Klin Wochenschr; 1964 Apr; 42():400-2. PubMed ID: 14214537
    [No Abstract]   [Full Text] [Related]  

  • 7. [EXPERIMENTS ON THE ISOLATION OF KALLIKREIN INACTIVATOR, IV. CRYSTALLIZATION AND AMINO ACID COMPOSITION. COMPARISON WITH THE TRYPSIN INHIBITOR OF KUNITZ AND NORTHROP].
    KRAUT H; BHARGAVA N; SCHULTZ F; ZIMMERMANN H
    Hoppe Seylers Z Physiol Chem; 1963; 334():230-5. PubMed ID: 14136713
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors.
    Antonini E; Ascenzi P; Bolognesi M; Gatti G; Guarneri M; Menegatti E
    J Mol Biol; 1983 Apr; 165(3):543-58. PubMed ID: 6188849
    [No Abstract]   [Full Text] [Related]  

  • 9. STATES OF AMINO ACID RESIDUES IN PROTEINS. V. DIFFERENT REACTIVITIES WITH H2O2 OF TRYPTOPHAN RESIDUES IN LYSOZYME, PROTEINASES AND ZYMOGENS.
    HACHIMORI Y; HORINISHI H; KURIHARA K; SHIBATA K
    Biochim Biophys Acta; 1964 Nov; 93():346. PubMed ID: 14251313
    [No Abstract]   [Full Text] [Related]  

  • 10. ACUTE EXPERIMENTAL PANCREATITIS: ROLE OF A PROTEOLYTIC ENZYME INHIBITOR IN TREATMENT.
    SCHUTT AJ; WAKIM KG; BARTHOLOMEW LG; CAIN JC; BAGGENSTOSS AH
    JAMA; 1965 Mar; 191():905-9. PubMed ID: 14260223
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the kinetics of the reaction between kallikrein inactivator and trypsin].
    Pütter J
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1197-206. PubMed ID: 5301336
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1.
    Figarella C; Miszczuk-Jamska B; Barrett AJ
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():293-8. PubMed ID: 3202969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic enzyme pattern in rats as affected by dietary soybean flour.
    Konijn AM; Biek Y; Guggenheim K
    J Nutr; 1970 Mar; 100(3):361-8. PubMed ID: 5461705
    [No Abstract]   [Full Text] [Related]  

  • 14. [TRIAL EMPLOYMENT OF A PROTEINASE INACTIVATOR IN THE TREATMENT OF LUMBAGO].
    RIFFAT G; DOMENACH J
    Lyon Med; 1965 Feb; 213():557-67. PubMed ID: 14303563
    [No Abstract]   [Full Text] [Related]  

  • 15. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
    Colomb E; Figarella C; Guy O
    Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IN VITRO AND IN VIVO STUDY OF A TRYPSIN INHIBITOR IN ACUTE PANCREATITIS: EXPERIMENTAL STUDY AND A REPORT OF ITS USE IN HUMAN CASE].
    DANI R; GODOY P; JARDIM MV; RASO P
    Hospital (Rio J); 1963 Sep; 64():635-49. PubMed ID: 14112146
    [No Abstract]   [Full Text] [Related]  

  • 17. THE IN VIVO INHIBITION OF THE CARDIOTOXIC AND OTHER DESTRUCTIVE ACTIONS OF CERTAIN PROTEOLYTIC ENZYMES BY AN ENZYME-INACTIVATOR.
    BAJUSZ E
    Arzneimittelforschung; 1964 Nov; 14():1188-90. PubMed ID: 14317928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the activation of bovine chymotrypsinogen and trypsinogen by determination of the N-terminal residues in these proteins and their corresponding enzymes].
    ROVERY N; FABRE C; DESNUELLE P
    Biochim Biophys Acta; 1953 Dec; 12(4):547-59. PubMed ID: 13140264
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural changes in the activation of chymotrypsinogen and trypsinogen; effect of urea on chymotrypsinogen and delta-chymotrypsin.
    DREYER WJ; NEURATH H; RUPLEY JA
    Arch Biochem Biophys; 1956 Nov; 65(1):243-59. PubMed ID: 13373422
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
    Rinderknecht H; Renner IG; Abramson SB; Carmack C
    Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.